PTCT · earnings call history
PTC Therapeutics Q2 FY26 — Record Revenue and Raised Guidance Driven by Strong Sephience Launch
Read the briefPTC Therapeutics Q1 FY26 — Record Revenue and Raised Guidance Driven by Sephience Launch
Read the briefBrowse all US companies on the earnings-call register.